These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14561756)

  • 1. The caveolin scaffolding domain modifies 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor binding properties by inhibiting phospholipase A2 activity.
    Gaudreault SB; Chabot C; Gratton JP; Poirier J
    J Biol Chem; 2004 Jan; 279(1):356-62. PubMed ID: 14561756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus.
    Chabot C; Gagné J; Giguère C; Bernard J; Baudry M; Massicotte G
    Hippocampus; 1998; 8(3):299-309. PubMed ID: 9662143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melittin increases AMPA receptor affinity in rat brain synaptoneurosomes.
    Bernard J; Chabot C; Gagné J; Baudry M; Massicotte G
    Brain Res; 1995 Feb; 671(2):195-200. PubMed ID: 7743208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPA receptor modulation in previously frozen mouse brain sections: opposite effects of calcium in the cortex and hippocampus.
    Lapierre L; Valastro B; Miceli D; Massicotte G
    Hippocampus; 2000; 10(6):645-53. PubMed ID: 11153710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of glutamate receptors by phospholipase A2: its role in adaptive neural plasticity.
    Massicotte G
    Cell Mol Life Sci; 2000 Oct; 57(11):1542-50. PubMed ID: 11092449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/quisqualate receptors by phospholipase A2: a necessary step in long-term potentiation?
    Massicotte G; Vanderklish P; Lynch G; Baudry M
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1893-7. PubMed ID: 1848014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental changes in depolarization-mediated AMPA receptor modifications and potassium-induced long-term potentiation.
    Chabot C; Bernard J; Normandin M; Ohayon M; Baudry M; Massicotte G
    Brain Res Dev Brain Res; 1996 May; 93(1-2):70-5. PubMed ID: 8804693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPA receptor phosphorylation is selectively regulated by constitutive phospholipase A(2) and 5-lipoxygenase activities.
    Ménard C; Valastro B; Martel MA; Chartier E; Marineau A; Baudry M; Massicotte G
    Hippocampus; 2005; 15(3):370-80. PubMed ID: 15630695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phospholipase A2 inhibitor bromophenacyl bromide prevents the depolarization-induced increase in [3H]AMPA binding in rat brain synaptoneurosomes.
    Bernard J; Lahsaïni A; Baudry M; Massicotte G
    Brain Res; 1993 Nov; 628(1-2):340-4. PubMed ID: 7508812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase A2 modulates different subtypes of excitatory amino acid receptors: autoradiographic evidence.
    Catania MV; Hollingsworth Z; Penney JB; Young AB
    J Neurochem; 1993 Jan; 60(1):236-45. PubMed ID: 7678040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/quisqualate receptors by phospholipase A2 treatment.
    Massicotte G; Baudry M
    Neurosci Lett; 1990 Oct; 118(2):245-8. PubMed ID: 2177177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of group V phospholipase A2 in caveolin-enriched granules in activated P388D1 macrophage-like cells.
    Balboa MA; Shirai Y; Gaietta G; Ellisman MH; Balsinde J; Dennis EA
    J Biol Chem; 2003 Nov; 278(48):48059-65. PubMed ID: 12963740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the AMPA receptor by phospholipase A2: effect of the antidepressant trimipramine.
    Bernard J; Ohayon M; Massicotte G
    Psychiatry Res; 1994 Feb; 51(2):107-14. PubMed ID: 7912839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition.
    Mira JP; Dubois T; Oudinet JP; Lukowski S; Russo-Marie F; Geny B
    J Biol Chem; 1997 Apr; 272(16):10474-82. PubMed ID: 9099690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.
    Fonteh AN; Atsumi G; LaPorte T; Chilton FH
    J Immunol; 2000 Sep; 165(5):2773-82. PubMed ID: 10946309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role for calcium-independent phospholipase A in alpha-amino-3-hydroxy-5-methylisoxazole-propionate receptor regulation during long-term potentiation.
    Martel MA; Patenaude C; Ménard C; Alaux S; Cummings BS; Massicotte G
    Eur J Neurosci; 2006 Jan; 23(2):505-13. PubMed ID: 16420457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions.
    Petegnief V; Saura J; Dewar D; Cummins DJ; Dragunow M; Mahy N
    Neuroscience; 1999; 94(1):105-15. PubMed ID: 10613501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA receptor-mediated regulation of AMPA receptor properties in organotypic hippocampal slice cultures.
    Gellerman DM; Bi X; Baudry M
    J Neurochem; 1997 Jul; 69(1):131-6. PubMed ID: 9202303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of cytosolic phospholipase A2 as mediator of the enhanced arachidonic acid release from dimethyl sulphoxide differentiated U937 cells.
    Withnall MT; Pennington A; Wiseman D
    Biochem Pharmacol; 1995 Nov; 50(11):1893-902. PubMed ID: 8615870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol- and caveolin-rich membrane domains are essential for phospholipase A2-dependent EDHF formation.
    Graziani A; Bricko V; Carmignani M; Graier WF; Groschner K
    Cardiovasc Res; 2004 Nov; 64(2):234-42. PubMed ID: 15485682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.